Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Statins in children cut long-term CVD risk in familial hypercholesterolemia

Publish date:: November 11, 2019

Key clinical point: Statins started in childhood for patients with familial hypercholesterolemia can reduce carotid thickening and cut the risk of cardiovascular disease.

Major finding: Follow-up LDL cholesterol levels at 20 years for those with familial hypercholesterolemia dropped 32% from baseline in the original study, compared with a 24% increase in the unaffected siblings.

Study details: A 20-year follow-up study of 184 patients with familial hypercholesterolemia and 77 unaffected siblings who had participated in a 2-year, placebo-controlled statin trial.

Disclosures: The study was supported by a grant from the AMC Foundation. The study authors reported disclosures related to numerous pharmaceutical companies and government, nonprofit, or academic entities.

Citation:

Kastelein JJP et al. N Engl J Med. 2019;381:1547-56.

This Week's Must Reads

Reduced kidney function linked to fractures in older women,

New evidence further supports starting CRC screening at age 45,

Health benefits of TAVR over SAVR sustained at 1 year,

Bariatric Surgery Tied to Fewer Cerebrovascular Events,

Fibrosis scoring systems have ‘modest’ predictive value in general population,

Must Reads in Cardiology

Health benefits of TAVR over SAVR sustained at 1 year,

Intensive BP control reduced dementia but increased brain atrophy and hurt cognition,

Cardiac arrests peak with pollution in Japan,

Icosapent ethyl cost effective in REDUCE-IT analysis,

Colchicine cut post-MI CVD events,